The FDA just approved Viramune (nevirapine)

The FDA just approved Viramune (nevirapine)...the FIFTH new antiviral for HIV in just the last 6 months.

It'll be out early next month...from Boehringer Ingelheim.

Viramune is the first drug in a new class called non-nucleoside reverse transcriptase inhibitors. It inhibits the same enzyme as AZT...but it works in a different way.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote